Related Experiment Video
Updated: Jun 19, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
Clinical and basic science advances in the treatment of HIV-1 and its associated kidney disease
1Division of Nephrology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Insights
The highly active antiretroviral therapy (HAART) era has increased kidney disease in HIV-1 patients. This review covers HIVAN, drug toxicity, and other kidney disease causes, plus treatments and transplantation.
Area of Science:
- Nephrology
- Infectious Diseases
- Immunology
Background:
- Improved survival in the post-highly active antiretroviral therapy (HAART) era has led to increased incidence of acute and chronic kidney disease in human immunodeficiency virus type 1 (HIV-1) infected patients.
- HIV-1 associated kidney disease encompasses a broad spectrum of clinical and histopathological conditions, with HIV-associated nephropathy (HIVAN) being the most severe.
- Other contributing factors include antiviral therapy toxicity, hepatitis C co-infection, and substance use.
Purpose of the Study:
- To review the pathophysiological principles of HIV-1 associated kidney diseases.
- To discuss various kidney disease contributors, including HIVAN, thrombotic microangiopathy, and drug-related nephrotoxicity.
- To present current and emerging therapeutic options and the role of organ transplantation.
Main Methods:
- Literature review focusing on pathophysiological mechanisms, clinical presentations, and therapeutic strategies for HIV-1 associated kidney diseases.
- Analysis of factors contributing to kidney disease in HIV-1 infected individuals.
- Discussion of recent advances and future directions in management and treatment.
Main Results:
- HIVAN remains a significant cause of kidney disease directly linked to HIV-1.
- Drug toxicity, co-infections, and lifestyle factors significantly contribute to renal morbidity in HIV-1 patients.
- Emerging therapies, including cyclin-dependent kinase inhibitors and organ transplantation, show promise.
Conclusions:
- Early diagnosis and prompt treatment are crucial for managing kidney disease in HIV-1 patients.
- Heightened awareness and targeted interventions are necessary, especially for vulnerable populations.
- A comprehensive approach addressing direct viral effects, comorbidities, and treatment toxicities is essential for improving renal outcomes.
Abstract:
With improved survival in the post-highly active antiretroviral therapy (HAART) era, we have witnessed an increase in the incidence of both acute and chronic kidney disease among patients with human immunodeficiency virus (HIV-1) infection. Much has been learned in the past three decades about the pathophysiological concepts of HIV-1 infection and its association with kidney disease. The extent of HIV-1 associated kidney disease is vast and represents a variety of clinical and histopathological conditions. While HIV-associated nephropathy (HIVAN) remains the most sinister kidney disease related to the direct effects of HIV-1, there are other contributors to kidney disease such as toxic effects of antiviral therapy, high prevalence of hepatitis C, cigarette, and injection drug use. This review presents the pathophysiological principles behind HIV-1 associated kidney diseases, with particular attention to thrombotic microangiopathy, drug-related kidney disease and HIVAN. Therapeutic options such as HAART, corticosteroids and angio-tensin-converting enzyme inhibitors are discussed. Advances in basic science medicine provided some insights into the role of cyclin-dependent kinase inhibitors as a potential therapeutic option for HIVAN. The emerging role of organ transplantation in HIV patients with kidney disease is also presented. Emphasis is placed on early diagnosis and timely treatment of kidney disease and heightened awareness particularly among the vulnerable population that bears most of the disease burden.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Kidney Transplant I: Introduction
Acute Kidney Injury II: Pathophysiology
